Analysis
Tyson Foods (TSN): Improvement trends are hinged on vaccine availability
Shares of Tyson Foods Inc. (NYSE: TSN) remained in red territory on Tuesday. The stock has dropped 29%...
Analysis
Expert equity analysis, earnings previews, and data-driven market research.
Latest Research
1,807 articles
Analysis
What awaits Best Buy (BBY) beyond pandemic-driven boom?
Shares of Best Buy Co. (NYSE: BBY) climbed to an all-time high this month even as the pandemic-driven...
Analysis
COVID-19 vaccine: Pfizer (PFE) and Moderna (MRNA) are ahead in the race, where are the others?
Pfizer Inc. (NYSE: PFE) and Moderna Inc. (NASDAQ: MRNA) have made significant progress in their efforts to develop...
Analysis
Can COVID vaccine be a panacea for Novavax’s (NVAX) growth needs?
The market has been closely following the activities of leading biopharma companies for some time, looking for updates...
Analysis
Will the new business model help Cisco (CSCO) regain past glory?
Network gear maker Cisco Systems, Inc. (NASDAQ: CSCO) has been on a drive to change the business model...
Analysis
DraftKings (DKNG) sees strong engagement trends due to return of major sports
Shares of DraftKings Inc. (NASDAQ: DKNG) were up over 4% in afternoon hours on Friday. The stock has...
ADVERTISEMENT
Analysis
The high point and low point of Walt Disney’s (DIS) Q4 2020 earnings report
The COVID-19 pandemic has caused a massive disruption to the Walt Disney Company’s (NYSE: DIS) operations over the...
Analysis
BJ’s Wholesale shifts to expansion mode to retain crisis-driven momentum
BJ’s Wholesale Club Holdings, Inc (NYSE: BJ) has maintained a strategy that is based on transformation ever since...
Analysis
Pinduoduo (PDD) sees significant opportunity in smart agriculture
Shares of Pinduoduo Inc. (NASDAQ: PDD) soared on Thursday, jumping over 20% in afternoon hours. The stock has...
Analysis
Beyond Air (XAIR) has hopes pinned on these two product opportunities for next year
Shares of Beyond Air Inc. (NASDAQ: XAIR) gained over 3% in midday trade on Thursday. The stock has...
Analysis
Lam Research (LRCX) has what it takes to tap into opportunities
After sending out mixed cues in the early weeks of the pandemic, Lam Research Corp. (NASDAQ: LRCX) has...
Analysis
Biogen (BIIB) might need to revisit pipeline after Alzheimer’s drug setback
The controversy surrounding biotechnology firm Biogen’s (NASDAQ: BIIB) Alzheimer’s drug Aducanumab took a positive turn last week after...